Globus Medical expects the Nevro acquisition to be accretive to its earnings in the second year of operation. Globus Medical expects to report full financial results for 2024 and provide its updated ...
“We are thrilled to join Globus Medical as this will allow us to reach more patients globally with clinically proven, innovative products that significantly reduce the burden of chronic pain ...
Get to Know Globus Medical Better Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers.
and regenerative biologic products comprising of allografts and synthetic alternatives. Receive News & Ratings for Globus Medical Daily - Enter your email address below to receive a concise daily ...
Globus Medical (NYSE:GMED) said it has agreed to buy Nevro (NVRO) through an all-cash deal with an equity value of around $250M. Under the deal, Globus Medical (NYSE:GMED) will buy all of Nevro's ...
“We are thrilled to join Globus Medical as this will allow us to reach more patients globally with clinically proven, innovative products that significantly reduce the burden of chronic pain ...
Globus Medical said the purchase would increase its portfolio of musculoskeletal technologies, therefore enhancing its position in neuromodulation and chronic pain management. Nevro, with its ...
The CEO of Globus Medical said the deal will enable the Audubon ... and manufacturing orthopedic implants and regenerative products for musculoskeletal disorders. CEO Dan Scavilla said the deal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results